These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 31899397)

  • 1. T2 Fluid-Attenuated Inversion Recovery Resection for Glioblastoma Involving Eloquent Brain Areas Facilitated Through Awake Craniotomy and Clinical Outcome.
    Lu M; Fu ZH; He XJ; Lu JK; Deng XQ; Lin DL; Gu YM; Fan YF; Lai MY; Li J; Yang MM; Chen ZP
    World Neurosurg; 2020 Mar; 135():e738-e747. PubMed ID: 31899397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
    J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li YM; Suki D; Hess K; Sawaya R
    J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?
    Clavreul A; Aubin G; Delion M; Lemée JM; Ter Minassian A; Menei P
    J Neurooncol; 2021 Jan; 151(2):113-121. PubMed ID: 33394262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Merits of Awake Craniotomy for Glioblastoma in the Left Hemispheric Eloquent Area: One Institution Experience.
    Li YC; Chiu HY; Lin YJ; Chen KT; Hsu PW; Huang YC; Chen PY; Wei KC
    Clin Neurol Neurosurg; 2021 Jan; 200():106343. PubMed ID: 33158628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
    Di L; Shah AH; Mahavadi A; Eichberg DG; Reddy R; Sanjurjo AD; Morell AA; Lu VM; Ampie L; Luther EM; Komotar RJ; Ivan ME
    J Neurosurg; 2023 Jan; 138(1):62-69. PubMed ID: 35623362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of removed tumor volume and location on patient outcome in glioblastoma.
    Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
    J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extent of resection of T2-flair hyperintense area for eloquent glioblastomas: outcomes analysis between awake and general anesthesia patients.
    Curzi C; Giordan E; Guerriero A; Bendini M; Canova G; Feletti A; Marton E
    J Neurosurg Sci; 2023 Aug; 67(4):480-490. PubMed ID: 34114434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical benefits of combined awake craniotomy and intraoperative magnetic resonance imaging for gliomas associated with eloquent areas.
    Motomura K; Natsume A; Iijima K; Kuramitsu S; Fujii M; Yamamoto T; Maesawa S; Sugiura J; Wakabayashi T
    J Neurosurg; 2017 Oct; 127(4):790-797. PubMed ID: 28059650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of combined intraoperative electrophysiological investigation with 3-T intraoperative MRI for awake cerebral glioma surgery: comprehensive review of the clinical implications and radiological outcomes.
    Ghinda D; Zhang N; Lu J; Yao CJ; Yuan S; Wu JS
    Neurosurg Focus; 2016 Mar; 40(3):E14. PubMed ID: 26926054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of awake mapping on overall survival and extent of resection in patients with adult diffuse gliomas within or near eloquent areas: a retrospective propensity score-matched analysis of awake craniotomy vs. general anesthesia.
    Fukui A; Muragaki Y; Saito T; Nitta M; Tsuzuki S; Asano H; Kawamata T
    Acta Neurochir (Wien); 2022 Feb; 164(2):395-404. PubMed ID: 34605985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study.
    Gerritsen JKW; Zwarthoed RH; Kilgallon JL; Nawabi NL; Jessurun CAC; Versyck G; Pruijn KP; Fisher FL; Larivière E; Solie L; Mekary RA; Satoer DD; Schouten JW; Bos EM; Kloet A; Nandoe Tewarie R; Smith TR; Dirven CMF; De Vleeschouwer S; Broekman MLD; Vincent AJPE
    Lancet Oncol; 2022 Jun; 23(6):802-817. PubMed ID: 35569489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SAFE-trial: Safe surgery for glioblastoma multiforme: Awake craniotomy versus surgery under general anesthesia. Study protocol for a multicenter prospective randomized controlled trial.
    Gerritsen JKW; Klimek M; Dirven CMF; Hoop EO; Wagemakers M; Rutten GJM; Kloet A; Hallaert GG; Vincent AJPE
    Contemp Clin Trials; 2020 Jan; 88():105876. PubMed ID: 31676314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.
    Mampre D; Ehresman J; Pinilla-Monsalve G; Osorio MAG; Olivi A; Quinones-Hinojosa A; Chaichana KL
    Br J Neurosurg; 2018 Oct; 32(5):528-535. PubMed ID: 30073866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
    Coburger J; Hagel V; Wirtz CR; König R
    PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.
    Höhne J; Schebesch KM; de Laurentis C; Akçakaya MO; Pedersen CB; Brawanski A; Poulsen FR; Kiris T; Cavallo C; Broggi M; Ferroli P; Acerbi F
    World Neurosurg; 2019 May; 125():e158-e164. PubMed ID: 30682505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awake craniotomy versus craniotomy under general anesthesia without surgery adjuncts for supratentorial glioblastoma in eloquent areas: a retrospective matched case-control study.
    Gerritsen JKW; Viëtor CL; Rizopoulos D; Schouten JW; Klimek M; Dirven CMF; Vincent AJE
    Acta Neurochir (Wien); 2019 Feb; 161(2):307-315. PubMed ID: 30617715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which Parameter Is More Important for the Prognosis of New-Onset Adult Glioblastoma: Residual Tumor Volume or Extent of Resection?
    Xing Y; Wang X
    World Neurosurg; 2018 Aug; 116():e444-e451. PubMed ID: 29753893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.